Price to Book Value Chart

View Price to Book Value for UCBJF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2010. Start Trial.
Date Value
August 03, 2026 8.257
July 31, 2026 8.439
July 30, 2026 8.124
July 29, 2026 9.250
July 28, 2026 8.778
July 27, 2026 9.008
July 24, 2026 9.094
July 23, 2026 8.682
July 22, 2026 8.682
July 21, 2026 8.682
July 20, 2026 8.889
July 17, 2026 8.551
July 16, 2026 8.750
July 15, 2026 8.617
July 14, 2026 8.502
July 13, 2026 8.742
July 10, 2026 8.854
July 09, 2026 9.290
July 08, 2026 9.258
July 07, 2026 9.289
July 06, 2026 9.233
July 02, 2026 9.626
July 01, 2026 9.552
June 30, 2026 9.815
June 29, 2026 9.710
Date Value
June 26, 2026 9.473
June 25, 2026 9.286
June 24, 2026 9.025
June 23, 2026 9.101
June 22, 2026 8.992
June 18, 2026 9.226
June 17, 2026 9.402
June 16, 2026 9.300
June 15, 2026 9.706
June 12, 2026 10.05
June 11, 2026 9.701
June 10, 2026 9.760
June 09, 2026 9.704
June 08, 2026 9.142
June 05, 2026 9.818
June 04, 2026 9.734
June 03, 2026 8.895
June 02, 2026 8.895
June 01, 2026 9.606
May 29, 2026 8.775
May 28, 2026 8.973
May 27, 2026 9.070
May 26, 2026 9.070
May 22, 2026 8.460
May 21, 2026 8.833

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Johnson & Johnson 7.597
AstraZeneca PLC 10.66
ANI Pharmaceuticals, Inc. 2.802
Corcept Therapeutics, Inc. 17.41
Veru, Inc. 1.577

Price to Book Value Related Metrics